Summary.-The concentration of cellular oestrogen receptor (RE) was measured in both the soluble and nuclear-pellet fractions of biopsies from 1,000 breast cancers.
in both fractions of primary disease was found to be an unreliable index of RE status in subsequent secondary disease, whereas RE-negativity was maintained during progression from primary to secondary disease. Other aspects of RE status in relation to stage of disease are analysed.
ENDOCRINE THERAPY is a long-established treatment of secondary breast cancer (Beatson, 1896) . It is, however, successful in only a small (, 25%) proportion of cases (King & Roberts, 1979) . The choice of endocrine therapy for a particular patient has been made on the basis of several clinical features, such as menopausal status, disease-free interval, site of dominant lesion, etc., and the response to any earlier endocrine therapy (Pearson & Ray, 1960; McGuire et al., 1977) . The absence of a single reliable index of hormone dependence of breast tumours has led to a marked decrease in recent years of the use of ablative therapies.
Preliminary data from our laboratory (Laing et al., 1977) 
Methods
Tissue fractionation.-Tissue was collected fresh and transported from the operating theatre to the laboratory on ice. Wherever possible, RE assay was performed the same day, but, when this could not be achieved, storage was at -20°C in sucrose buffer (0-25M sucrose, 1-5mM MgCl2, 10mM Hepes, pH 7.4)/50% glycerol (v:v) (Leake et al., 1979) . Soluble and nuclear fractions were then prepared as follows.
About 150 mg of tissue was dissected from the area adjacent to that removed for pathological examination. Homogenization was carried out at 50 mg/ml in 10mM Hepes, 1 5mM EDTA, 0-25mM DTT, pH 7-4 (HED buffer) using 2 x 10s bursts at a setting of 150 on an Ultra-Turrax, model TP 18/2, followed by further homogenization with a glass tissue grinder (Kontes Duall). The homogenate was centrifugated at 5000 g for 5 min at 4°C to yield a "cytosol" supernatant and a crude nuclear pellet. The pellet was washed x 3 in 0-15M NaCl, 10mM Hepes (pH 7.4), and finally resuspended to the original volume in buffered saline. A wash with 0.1% Triton X-100 was on occasion incorporated at this stage to further purify the nuclear material, but this did not appreciably alter the level of nuclear binding. Further purification of the pellet fraction by differential centrifugation through sucrose (finally 2f4M sucrose, 1 5mM MgC92) did not significantly alter RE content expressed per unit DNA.
Assay of receptors.-The initial procedures in the assay system were identical for both tissue fractions. 1501p aliquots of cytosol or nuclear suspension were added to 50u1l aliquots of 3H-oestradiol-17/ to give final concentrations of steroid of 1, 1-5, 2, 4, 6 and 8 x 10-10M. Two additional tubes were also set up containing 10-9M 3H-oestradiol with or without 10-7M unlabelled diethylstilboestrol (DES) to determine the specificity of binding. All tubes were then incubated at 4°C for 18 h. The inclusion of protease inhibitors Trasylol and/or phenylmethylsulphonyl fluoride (PMSF) in the incubation medium did not appear to enhance RE measurement. After incubation, the amount of steroid bound was determined for each fraction as follows.
Cytosol receptors (REc).-At the end of the incubation period, 0-9 ml of 1 5mM EDTA, 10mM Hepes (pH 7.4) and 0 5 ml Dextrancoated charcoal (0X15% (w:v) charcoal and 0-0015% (w: v) dextran T-70, equilibrated in 025M sucrose, 1 5mM EDTA, 10mM Hepes, pH 7.4) were added to each tube. This mixture was agitated at 0°C for 15 min followed by centrifugation at 1000 g for 5 min. To lml aliquots of each supernatant was added 10 ml Triton-toluene scintillant (200 ml ethanol: 600 ml Triton X-100: 1400 ml toluene/PPO (5 g/l)/POPOP (0-24 g/l)) and each counted at 25% efficiency in a Philips or at 30% in a Searle Mark III Liquid Scintillation analyser.
Nuclear receptors (REN).-Following incubation, 1001ul aliquots were removed from each tube and added to 5ml saline. This mixture was poured down the chimney of a Millipore filter apparatus on to a pre-wetted Whatman GF/C glass-fibre filter. The tube was washed out with 5 ml saline, the washing poured on to the filter and the filter further washed with 3 x 4 ml saline under suction. After removal of the chimney, the edge of the filter was washed and the filter removed into a scintillation vial prior to drying overnight at 60°C. 10 ml toluene/PPO (5 g/l) scintillant was added, and the samples counted at 35% efficiency in a Philips or Searle Mark III Liquid Scintillation analyser.
Protein and DNA assay.-Cytosol protein concentration was determined by the method of Lowry. DNA content was determined by a modification of the method of Burton (1956) as described by Katzenellenbogen & Leake (1974) .
Definition of positivity
To be classed as RE+ the binding displayed by either tissue fraction was required to fulfil 3 criteria: (a) yield an unambiguous Scatchard plot, which produces (b) a straight line, giving a Kd in the range 0 5-5 x 10-10M; (c) specificity must be established by competition with excess diethylstilboestrol. RE concentrations as low as 3 fmol/mg protein and 25 fmol/mg DNA were detected for the soluble and pellet fractions respectively.
Response to hormone therapy was assessed in patients with secondary disease for whom (a) RE status had been determined before the initiation of any therapy, (b) endocrine therapy alone was applied as first treatment during the period of assessment. The criteria for response were those suggested by the British Breast Group (1974) . In brief, these involve at least 50% regression of existing lesions, and no appearance of new lesions within a 6-month period. Only patients satisfying these criteria for at least 6 months are recorded as having responded (Table  VII) .
RESULTS

Primary disease
The distribution of patients by RE status is shown in Table I or completely lacking in REc (0/0). This is, perhaps, surprising in view of the concept that absence of RE indicates a more rapidly progressing tumour (Meyer et al., 1977) . The distribution of RE was also reanalysed in relation to nodal status. It was thought that patients with REtumours would be more likely to exhibit nodal involvement than those with RE+ disease. However, the data in Table IV do (King, 1975; Jensen, 1975) . However, practical demonstration of the stability of RE status between biopsy and the appear- ance of secondary disease has been limited due to the difficulties in (a) maintaining a stable patient population and (b) obtaining sufficient material from the metastatic site. (Leake et al., 1979) and chemotherapy have been found to either block RE synthesis or interfere with the RE assay, but this patient had received no such relevant therapy prior to biopsy.
Thus a RE-primary is almost certain to give rise to hormone insensitive secondary disease.
When RE status is compared between first occurrence and later recurrences (Table VI) Table VII. Patients whose biopsies showed an intact RE system had a very good chance of responding to some type of endocrine therapy (most commonly tamoxifen treatment). Only 5 patients (9 %) of those in the truly RE-class showed good response. In each case these patients had received tamoxifen, and may have responded to one of the actions of this drug which is not RE-mediated (Tisdale, 1977) . It is striking that the patients whose biopsies contained RE in only one fraction (0/+ or + /0) behaved in a manner similar to the RE-group, suggesting that these receptors are non-functional, though there is no indication whether the fault lies in the RE itself or in some cellular recognition site. Of the patients in Table VII , those who did not experience a complete response for 6 months were divided as follows: in the ( + / + ) category 8 had progressive disease, 1 was static and 3 showed a partial response; in the (0/0) category 48 had progressive disease, 3 were static and 2 showed a partial response; in the (+/0) category 10 had progressive disease, 1 was static and 2 showed partial response; in the (0/ + ) category all 8 patients had progressive disease. Of the 129 patients considered, only 27 were pre-menopausal and 10 menopausal. The response rates quoted, therefore, apply principally to post-menopausal disease. It is, however, significant that 18/27 pre-menopausal patients had both biopsies with no detectable RE (0/0) and suffered progressive disease. Of the 42 patients experiencing complete response, 18 had local recurrence, 10 had recurrence in gland and/or skin, 7 in bone and the remainder at one or more distant sites. Of 74 patients with progressive disease, 13 had local recurrence, 21 skin and/or gland, 21 bone, 7 pleura, 7 liver and the remainder at one or more distant sites.
DISCUSSION
Both established dogma (Leake, 1976) and recent interpretations (Sheridan et al., 1979) of steroid hormone action essentially require that functional hormone RE complex forms an equilibrium between the soluble and nuclear-pellet fractions of the cell. Such an equilibrium is rapidly established at 37°C, but can also be established at 0°C over 22 h (Traish et al., 1979) . Similarly, the distribution of RE between the soluble and nuclear-pellet fractions of target tissue has also been successfully measured at both 37°C and 4°C by use of different incubation times, though the decreased stability of receptor at 37°C in the cell-free environment meant that assay at 4°C (or 20°C) gave more reproducible results (Leake et al., 1979) . Thus, hormonal dependence of a particular human breast tumour biopsy should be reflected in the presence of measurable quantities of RE in both soluble and pellet fractions of said biopsy.
After adopting strict criteria for the measurement of cellular RE (Leake et al., 1979) it was found that only one-third of patients with primary disease yielded biopsies containing functional RE (Table  I) , i.e. RE in both soluble and pellet fractions. Biopsies from about half the patients had undetectable levels of highaffinity RE. This is a surprisingly large proportion, but has been maintained throughout the study. Further, the low rate of response of advanced disease to hormone therapy in patients lacking RE (Table VII) , taken together with the observation that RE-(0/0) primaries give rise to RE-secondaries ( Table V) , suggest that such a high incidence of hormonal insensitivity is real. The 2 initially unexpected groups of patients (+ /0) and (0/ + ) (Laing et al., 1977) continue to present. Such patients with RE in one fraction of the biopsy only have now also been observed in other studies (Panko & MacLeod, 1978;  Thorsen, 1979; Barnes et al., 1979) .
Much of the value of determining RE status in primary disease depends upon the assumption that in subsequent secondary disease RE status will faithfully reflect that in the primary biopsy. However, in a study of 32 patients for whom RE status was determined in both primary and advanced disease (Table V) , only half the primaries with fully functional RE gave rise to ( + / + ) secondaries. This is a disappointingly low level of consistency of RE status between primary and secondary disease, but may reflect the fact that the secondary samples are necessarily selected from surgically accessible sites. The consistency of RE status might be higher if all sites of secondary disease were con-sidered. These patients had received no adjuvant therapy, so the loss of RE must have resulted during the natural progression of the disease. Further studies in progress may clarify this situation.
It was more encouraging to find that RE status in only 1 patient out of 17 reverted from RE-primary to fully RE+. Patients whose receptors fell in the abnormal categories (+/0 or 0/ +) were found to show a high level of variation between primary and secondary disease. However, there were no cases of change to RE+ status. Hence patients whose primaries are either RE-or abnormal have very little chance of subsequently responding to hormonal manipulation.
The follow-up data in Table VII show that patients whose biopsies of secondary disease contain fully functional RE have a much better chance of objective response to human manipulation than do those with either no RE or RE in one fraction only. The criteria of clinical response used in this paper are quite severe (British Breast Group, 1974 ) similar to those proposed by the UICC (Hayward et al., 1977) . Stoll (1977) proposed shorter periods of sustained response. Adoption of less stringent criteria will increase the response rate in any series. However, no biological index is ever likely to identify potential responders with complete accuracy, since so many variables are involved. Alternative indices of hormonal-dependence have been tried, and perhaps the most successful is measurement of soluble progesterone receptor, a product of oestrogen action in normal target tissue. Recent studies by Barnes et al. (1979) , Thorsen & Stoa (1979) and in our own laboratory suggest that although the presence of RP is not always associated with an improved clinical response, it is usually associated with the presence of fully functional RE and so yields a similar success rate in the identification of responders to hormone therapy. We are extremely grateful to the Cancer Research Campaign whose financial assistance has been essential to this study. We should also like to thank Professor R. M. S. Smellie for his provision of facilities and also for his helpful comments and criticisms. We are very pleased to acknowledge the co-operation of many of our surgical colleagues, especially Mr Frank Crossling, Mr Colin McArdle and Mr John Maxwell Anderson.
